Clinical Trial Update: Role of Mesenchymal Stromal Cell Derived Extracellular Vesicles of Primary Myelofibrosis Patients on CD34+ Cells

View source ↗

Summary

A recruiting study evaluating the effects of extracellular vesicles derived from mesenchymal stromal cells in patients with primary myelofibrosis on CD34+ cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• MSC-derived extracellular vesicles (extracellular vesicles from mesenchymal stromal cells)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Primary Myelofibrosis | Status: RECRUITING